PHOENIX UK and the British Heart Foundation has joined hands for a charity partnership to continue the ongoing commitment of improving heart health across the UK.
The PHOENIX team have set the donation goal of £20,000 by June 2023 and are set to take on a range of exciting challenges over the course of the next year, such as
a Tough Mudder and the Yorkshire Three Peaks challenge, all in a bid to raise funds for the heart health charity.
Nigel Swift, Managing Director of Rowlands, PHOENIX UK's largest community pharmacy member organisation, commented: "We are thrilled to be partnering with The British
Heart Foundation. Its lifesaving research perfectly aligns with our mission across PHOENIX UK - to enable more people to live happy and healthy lives - and so we
look forward to raising vital funds and supporting the excellent work of the charity."
Hayley Gough, Community Relationship Manager at The British Heart Foundation, added, "It's fantastic to see the team at PHOENIX UK commit to raising so much money
for The British Heart Foundation. We can't wait to see all that they achieve and are so grateful for their fundraising efforts."
The General Pharmaceutical Council has apologised for severe delays and disruptions during the June foundation registration assessment at five test centres in
England on Wednesday (June 29).
The pharmacy regulator said it has since "contacted the candidates affected via email to apologise for the disruption and the extra worry this will have caused.
"We will also be issuing our usual survey for all candidates so we can hear directly from them about their experiences and have also asked candidates to get in touch
if they would like individual advice."
GPhC admitted that the worse sufferers were the candidates at a test centre in Nottingham "where the delay was severe and candidates were only able to start Paper 1
in the late afternoon".
Extremely sorry
In a statement, Duncan Rudkin, chief executive of the GPhC, said: "We are extremely sorry for the severe delays experienced by candidates in Nottingham today. This
is completely unacceptable, and we fully appreciate the significant stress and disruption this must have caused for them in such a high-stakes assessment.
The National Pharmacy Association (NPA)'s Health Education Foundation (HEF) has funded a major study that aimed to test the SPUR tool and evaluate how effective
it was at measuring medicines adherence.
The study has been published in the British Medical Journal Open.
Dr Joshua Wells, a fourth year PhD candidate at Kingston University, who was awarded the NPA bursary, was the lead researcher for the SPUR UK study, under the
guidance of Professor Reem Kayyali.
Created by Observia, a health research group, SPUR is a self-assessment questionnaire which helps to detect a patient's risk of medicine non-adherence and aims to
accurately articulate the reasons for health behaviour.
As well as funding from HEF, the study was made possible via a partnership with Kingston University and Kingston Hospital.
HEF chair of Trustees, Dr Ian Cubbin, said: "We are delighted that NPA's Health Education Foundation has played a part in such an important study. This research could
lead ultimately to a far more personalised, tailored approach to medicines optimisation - recognising that people's medicines behaviour can be highly individual to
them."
Former Prime Minister Theresa May has formally opened new offices of LEO Pharma UK and Ireland during a launch event in Maidenhead, Berkshire.
The company said on Friday (June 16) that the new building, based at Foundation Park, will function as its UK and Ireland operational headquarters.
LEO Pharma has been manufacturing dermatology products in the UK and Ireland for over 60 years and continues its commitment to the Maidenhead area, where it been
based for 10 years. The grounds offer state-of-the-art facilities and a greener and more sustainable workplace, the company said and hoped that that strong transport
connections at Foundation Park will allow for seamless international collaboration, while a range of health and wellness initiatives will contribute to employee
wellbeing.
This new space will enable a collaborative and flexible work environment for LEO Pharma staff, ensuring they can continue to work to improve the lives of people
living with skin conditions, their families and society.
The International Pharmaceutical Federation (FIP) launched a report on pharmacy-led common ailment schemes.
The data was collected from 24 countries, including case studies from nine countries.
It highlighted the growing demand for care models for ageing populations and the increase in chronic non-communicable diseases.
Pharmacists had been managing the stress, including prescribing authority and provision of medicinal treatments.
Paul Sinclair AM, Global President of FIP, said, "I believe this report is both a foundation and a catalyst - a foundation on which FIP and our member
organizations could base initial strategies and a catalyst to drive us to seek even more diverse and comprehensive insights in the future.
If you're thinking of heading a startup, owning a local pharmacy could be an incredibly lucrative opportunity. When you set up a business in the healthcare
sector, it's important to ensure that you operate with transparency to keep yourself and your patients safe.
Whether you've acquired pharmacies before or you're turning to a new venture with different partners, learning the relevant steps before getting involved is
imperative. Successful pharmacies rely on medical expertise, professional knowledge, and an excellent quality of service.
Step 1: Do you need qualifications to be a pharmacist?
No matter if you already have a background in pharmacy or you're entering the field from an entrepreneurial perspective, you'll need to have the right qualifications.
You can become a pharmacist by completing a Master of Pharmacy degree at a university. Your chosen course needs to be approved by the General Pharmaceutical Council
and will take at least four years to complete. After your degree, you'll also need to take the one-year pharmacist foundation training scheme.
To access these courses, you'll usually need two or three A levels, including Chemistry. Alternatively, you could do a pharmacy foundation degree if you only have one
A level or equivalent.
The National Health Service (NHS) is embracing new technology and innovations like artificial intelligence (AI) to reduce the number of missed hospital
appointments and improve waiting times for elective care.
Following a successful pilot in Mid and South Essex NHS Foundation Trust, the health service is set to roll out AI software to 10 more trusts across England in
the coming months.
The software, developed by Deep Medical in collaboration with a frontline worker and NHS clinical fellow, helps reduce the number of missed appointments by
offering patients convenient time slots and backup booking options.
Since the AI programme was piloted six months ago, Mid and South Essex NHS Foundation Trust has seen a 30 per cent fall in non-attendances.
During the pilot period, a total of 377 did not attends (DNAs) were prevented and an additional 1,910 patients were attended.
Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy
contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector.
The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies.
Beginning August, the DHSC is set to claw back the amount.
McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies.
Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability
of many pharmacies.
"Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of their making, the Department of Health is
jeopardising the foundation of local healthcare delivery," McQuillan criticised.
Addressing the recent announcement made by the Department of Health and Social Care (DHSC) to claw back £9 million per month from community pharmacy
contractors, the Chairman of Numark, Harry McQuillan has expressed deep concerns over the financial implications on the sector.
The claw back follows an error in the July calculations of Category M medicine prices, which led to increase in the reimbursements made to community pharmacies.
Beginning August, the DHSC is set to claw back the amount.
McQuillan criticised the decision, highlighting the severe strain it places on already financially vulnerable community pharmacies.
Calling it "a severe blow to an already financially strained sector", McQuillan emphasised that the additional burden has the potential to threaten the viability
of many pharmacies.
"Community pharmacies are the frontline of our healthcare system, by penalising these pharmacies for an error not of thei
The Royal Pharmaceutical Society (RPS) England director, Ravi Sharma, has resigned after four years on the job.
He will be leaving the RPS in October to join Luton and Dunstable University Hospital, part of the Bedfordshire Hospitals NHS Foundation Trust group, as head of
pharmacy.
RPS will be commencing the recruitment of a new director for England shortly and in the interim Ravi will be working with Paul Bennett, the RPS CEO, to help in
delivery of key objectives and in the appointment of his successor.
Paul commented: "Ravi has made a significant contribution to the organisation during his time with us. His drive and enthusiasm for advancing the recognition of
the role of the Society itself and of pharmacists and professional practice is probably best reflected by his desire to ensure a real focus on personalised medicines
and his work on equality and diversity, workforce wellbeing, and most recently the development of a new vision for pharmacy in England.
Global instant logistics leader, Zipline is partnering with UK drone delivery startup, Apian Aero to launch a drone delivery programme of critical medical
supplies for the Northumbria Healthcare NHS Foundation Trust.
The new service, expected to begin in the autumn of 2024, will see delivery of medical supplies to hospitals, GPs and care homes, using electric, autonomous drones.
Zipline announced the partnership on Sunday, and said drone delivery service will help provide timely access to prescription medicines, wound care products, joint
replacement implants, and other frequently ordered medical products, which could allow healthcare providers to reduce the number of cancelled procedures, and thus
decrease wait times.
Also, the expansion of the programme will help in creating local job opportunities in the region, it added.
What initially began as two close friends taking a leisurely walk to escape their everyday routine has evolved into a meaningful endeavour to support the
fight against cancer.
Jamie Sparrow, Senior Vice President - Commercial, EMENA at Accord Healthcare, and Jamie Durbidge, Owner & Managing Director of Perennial Pharma, will be
undertaking a 5-day walking challenge to support The Luke Hart Foundation in raising funds for Cancer Research UK.
The two Jamies have been friends for more than 15 years and worked together at Mylan, now Viatris, where Jamie S served as Managing Director, while Jamie D held
the position of Sales Director for some years.
During the COVID pandemic when everybody was stuck at home, the two friends, both early risers, used to spend hours in the mornings walking and talking over the
phone, about anything and everything - work, life, family, the Pharmaceutical Industry, politics, sport, and about challenges that people were having during the
lockdown.
After continuing this routine for several months, they eventually planned to transform their daily ritual into a "walking and talking" trip to reconnect, catch
up on things, and enjoy some time together and with friends who wanted to join them.
The Company Chemists' Association (CCA) has raised concern that pharmacies may face challenges in providing placements to pharmacy students graduating in
2025 due to shortages of designated prescribing practitioners (DPPs).
From the academic year 2025/26, all pharmacy students will be required to complete 90 hours of training with designated prescribing practitioners prior to their
registration.
However, the CCA has raised doubts regarding the availability of these healthcare professionals to provide such training.
The association said: "We are concerned that pharmacies will be unable to secure DPPs. This will result in a significant reduction in the number of Foundation
Pharmacist placements available within the community pharmacy sector.
Consequently, a significant number of graduates leaving university next year will, unfortunately, struggle to find employment in their chosen career."
As per the CCA, they have repeatedly raised their concerns with NHS England and cautioned them about the potential consequences arising from the lack of DPPs.
Personel care items like cosmetic including mascara foundations, body lotions and soaps, hair style products very vital value regarding health and science. Everybody used toxic chemicals in the form of cosmetics. How we take good and healthy steps for good and safe beauty.
A daily medication for high blood pressure could be replaced by an injection twice a year, if Queen Mary University and Barts Health NHS Trust succeed in their trail to investigate if an injection-based drug - Zilebesiran - could inhibit the production of a protein called angiotensinogen (AGT).
Scientists are to trial a world-first drug to treat high blood pressure that can be given by injection twice a year.
Professor Sir Nilesh Samani, medical director, British Heart Foundation, said: "This exciting trial could lead to good news for the millions of people across the UK with high blood pressure, many of whom need to take daily medication to lower their risk of heart attacks and strokes.
"The study will determine whether an injection given twice a year lowers blood pressure sufficiently over a prolonged period.
"If this proves to be the case, it may provide an alternative to taking daily pills for some patients."
Throughout the past decade, digital transformation has been at the forefront of the agenda for the NHS which has been accelerated by the abundance of digitally enabled ways of working during the pandemic. While the last year has unquestionably heralded the spring shoots of transformation, there is so much to be done to build upon this and accelerate further.
For example, do both pharmacists and patients comprehend the value of digital to drive change at a fundamental level? The issue is not simply ensuring that the temporary fixes inspired by the pandemic successfully transition to standard practice, but also rapidly building on that foundation to enable the greatest
value from digitisation within pharmacy.
Covid-19 has increased the need for digitally enabled and empowered ways of operating. From the backlog in outpatient appointments to postponed screening programmes and, crucially, the potential exodus of overworked and stressed pharmacists, the efficient, effective and intelligent care enabled by the right digital technologies is now critical.
NHS England is set to roll out a new test this week that will help doctors to spot a rare form of eye cancer in babies in the womb.
The NHS test developed at Birmingham Women's and Children's NHS Foundation Trust, identifies the risk of developing retinoblastoma in babies that can be monitored
and treated sooner - increasing the chance of saving their eyesight and potentially their lives.
The new non-invasive test can detect changes in the genes in DNA and is likely to identify around 50 infants with retinoblastoma each year, in the latest example
of the NHS harnessing the power of genomics to diagnose and treat patients faster and more effectively.
Non-Invasive Prenatal Diagnosis (NIPD) also means parents can be informed early in pregnancy if their child is at risk.
"The blood sample test is taken from the mother before birth and tested and analysed for mutations, which can determine with almost 100 per cent accuracy if the baby will develop retinoblastoma," the NHS said.
A Orthodontic treatment should be carried out by qualified professionals round this time five years ago there was a surge in the reporting of people
performing DIY orthodontics on themselves in their own homes.
Mainstream media reported that video tutorials had emerged online with instructions on using small elastic bands to adjust teeth positions.
What followed were some horrendous pictures of irreparable damage to people's teeth and gums.
The trend escalated to a point where in 2017, the American Dental Association revealed that 13 per cent of patients had tried some kind of DIY teeth straightening
appliance that had backfired.
Now, we are seeing the situation further evolve, with private companies offering DIY orthodontic treatment under the term 'direct-to-consumer' orthodontics.
The Oral Health Foundation is becoming increasingly concerned with the rise of the DIY orthodontic market and the potential harmful consequences it could have for
millions of consumers.
The National Pharmacy Association (NPA) has appointed Paul Rees MBE as its new Chief Executive, with his role commencing on November 27th. Rees, currently
serving as the Chief Executive of the Royal College of Psychiatrists and having held various roles throughout his career, will succeed Mark Lyonette, who is
retiring, NPA said in a statement.
"We anticipate Paul joining the NPA after a thorough recruitment process affirmed his suitability," said Nick Kaye, Chair of NPA. "Throughout his career, including
his role at the Royal College of Psychiatrists, he has made a significant impact and achieved concrete changes in healthcare and society. I would also like to
express my appreciation to Mark for his work as Chief Executive since 2018. He still has important tasks to complete at the NPA before his retirement."
Rees has also held key positions at prominent organisations, including the Ramblers Association, National Housing Federation, Charities Aid Foundation, Association
of University Teachers, and the , besides being the Head of Communications at the Home Office.
The Pharmaceutical Services Negotiating Committee (PSNC) has commissioned Nuffield Trust and The King's Fund to develop a new vision and strategic options for
community pharmacy.
The report is expected to be published in early summer next year, to underpin the future strategy for the sector. It will also support negotiations between PSNC
and policymakers as the current five-year Community Pharmacy Contractual Framework (CPCF) comes to an end.
Those negotiations will decide what happens after April 2024, and they will be critical to the future of the sector.
The development of a compelling vision and an effective strategy for community pharmacy was a key recommendation from the Pharmacy Representation Review Steering
Group (RSG). It forms one of the workstreams of the Transforming Pharmacy Representation Programme (TAPR) currently being undertaken by PSNC. But it is also a project
that PSNC wants to undertake anyway to help lay the foundations for those crucial upcoming negotiations.